A 12 month prospective, observational study to observe the naturalistic outcomes and direct costs of treatment associated with stress urinary incontinence
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2010
At a glance
- Drugs Duloxetine (Primary)
- Indications Stress incontinence
- Focus Therapeutic Use
- 23 Apr 2010 Cost-utility analysis results published in Value in health.
- 16 Jun 2006 New trial record.